[1]
Frisch, A. et al. 2026. Refractory Epstein-Barr Virus-Negative Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder in a Renal Transplant Patient Treated With Bispecific Antibody Therapy. Journal of Medical Cases. 17, 1 (Jan. 2026), 1–8. DOI:https://doi.org/10.14740/jmc5186.